Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world evidence of mammography screening from the Hong Kong Breast Cancer Registry: a cost minimisation analysis of 15 144 patients with breast cancer.

BMJ public health·2026
Same author

Clinical and Imaging Abnormalities Associated With Inducible Ventricular Arrhythmias During Electrophysiologic Study in Patients With Cardiac Sarcoidosis and Mildly Impaired Left Ventricular Function.

Journal of the American Heart Association·2026
Same author

Right Atrial Mass as Manifestation of Sarcoidosis.

JACC. Case reports·2025
Same author

The Varying Histology of Hepatic Sarcoidosis and the Relation of Bile Duct Damage and Loss to the Presence of Portal Hypertension and Cirrhosis.

Gastro hep advances·2025
Same author

Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosis.

Heart rhythm·2024
Same author

Targeting mTOR in sarcoid granulomas: where the rubber meets the road.

The Lancet. Rheumatology·2024

Related Experiment Video

Updated: Jun 21, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K

Leveraging AI technology in sarcoidosis.

Akiff Premjee1, Lawrence Li1, Srilakashmi Garikapati1

  • 1Department of Medicine.

Current Opinion in Pulmonary Medicine
|July 11, 2024
PubMed
Summary

Artificial intelligence (AI) shows promise in addressing challenges in diagnosing and predicting outcomes for sarcoidosis patients. Future AI models, trained on diverse patient data, could significantly aid clinical decision-making in this complex disease.

More Related Videos

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.4K
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

560

Related Experiment Videos

Last Updated: Jun 21, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.4K
Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
04:10

Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy

Published on: July 19, 2024

560

Area of Science:

  • Medical Informatics
  • Pulmonology
  • Artificial Intelligence

Background:

  • Sarcoidosis is a systemic granulomatous disease with uncertain etiology, leading to diagnostic and prognostic difficulties.
  • Treatment response in sarcoidosis is often unpredictable, necessitating advanced clinical decision support.
  • Artificial intelligence (AI) offers potential solutions to these complex clinical challenges.

Purpose of the Study:

  • To review the current and potential future applications of AI in the field of sarcoidosis.
  • To explore how AI can assist in overcoming diagnostic, prognostic, and treatment-related uncertainties in sarcoidosis.

Main Methods:

  • Review of existing literature on AI applications in sarcoidosis.
  • Analysis of AI models for medical imaging, survival prediction, and patient phenotyping.
  • Discussion of limitations such as data accessibility, bias, cost, and privacy.

Main Results:

  • AI is predominantly used in sarcoidosis imaging to differentiate it from other pulmonary disorders.
  • AI models exist for predicting survival and identifying prognostic factors.
  • Research is ongoing for AI-driven patient phenotyping and treatment response prediction, with potential from other inflammatory diseases.

Conclusions:

  • AI in medicine, including sarcoidosis, is emerging and poised to support diagnostic and prognostic decision-making.
  • The predictive power of AI in sarcoidosis will likely increase by integrating diverse models trained on comprehensive datasets from heterogeneous patients.